Sameer Doshi - Publications, H-index & Citations

Sameer Doshi

amgen

20H指数

64论文数

1.3K被引数

收录论文 20

发表时间

Context Engineering for AI-Assisted Pharmacometrics: A Practical Tutorial 人工智能辅助药代动力学和药效动力学的语境工程：一个实用教程

CPT-Pharmacometrics & Systems Pharmacology

IF3

2026-09-15

OAAI

Ari Pritchard-Bell; Chih-Wei Lin; William Holmes; Sameer Doshi

Integration of Time-Varying Pharmacometric Modeling With Cox Regression for Time-to-Event Analysis in NONMEM 将时变药代动力学模型与Cox回归集成用于NONMEM中的时间-事件分析

cpt: pharmacometrics & systems pharmacology

IF0

2026-04-23

OAAI

Chih-Wei Lin; Po-Wei Chen; Sameer Doshi; Sandeep Dutta

A multistate platform model for time-to-event endpoints in oncology clinical trials

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2023-11-08

OAAI

Lin, Chih-Wei; Nagase, Mario; Doshi, Sameer; Dutta, Sandeep

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp Alfa, a Bispecific Inhibitor of BAFF and ICOSL: Analyses of Phase I Clinical Trials

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2023-05-24

OAAI

Abuqayyas, Lubna; Chen, Po-Wei; dos Santos, Marcia Teixeira; Parnes, Jane R.; Doshi, Sameer; Dutta, Sandeep; Houk, Brett E.

Establishing PK Equivalence Between Adalimumab and ABP 501 in the Presence of Antidrug Antibodies Using Population PK Modeling

CLINICAL THERAPEUTICS

IF3.6

2022-01-01

PREAI

Doshi, Sameer; Wang, Hui; Chow, Vincent

Quantification of Radiation Injury on Neutropenia and the Link between Absolute Neutrophil Count Time Course and Overall Survival in Nonhuman Primates Treated with G-CSF

PHARMACEUTICAL RESEARCH

IF4.3

2020-05-21

OAAI

Harrold, John; Gisleskog, Per Olsson; Delor, Isabelle; Jacqmin, Philippe; Jose Perez-Ruixo, Juan; Narayanan, Adimoolam; Doshi, Sameer; Chow, Andrew; Yang, Bing-Bing; Melhem, Murad

Exposure-response analysis of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukaemia and comparison with standard of care chemotherapy

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2019-02-18

OAAI

Kuchimanchi, Mita; Zhu, Min; Clements, John D.; Doshi, Sameer

Receiver Operating Characteristic Analysis and Clinical Trial Simulation to Inform Dose Titration Decisions

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2018-10-15

OAAI

Clements, John David; Ruixo, Juan Jose Perez; Gibbs, John R.; Doshi, Sameer; Ruixo, Carlos Perez; Melhem, Murad

Assessment of pharmacokinetic interaction between rilotumumab and epirubicin, cisplatin and capecitabine (ECX) in a Phase 3 study in gastric cancer

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2016-12-13

OAAI

Zhang, Yilong; Kuchimanchi, Mita; Zhu, Min; Doshi, Sameer; Hoang, Tien; Kasichayanula, Sreeneeranj

Pharmacokinetics and pharmacodynamics of rilotumumab: a decade of experience in preclinical and clinical cancer research

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2015-05-26

OAAI

Zhang, Y.; Doshi, S.; Zhu, M.

Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression

BRITISH JOURNAL OF CANCER

IF6.8

2015-01-13

OAAI

Zhu, M.; Tang, R.; Doshi, S.; Oliner, K. S.; Dubey, S.; Jiang, Y.; Donehower, R. C.; Iveson, T.; Loh, E. Y.; Zhang, Y.

Population Pharmacokinetics of Rilotumumab, a Fully Human Monoclonal Antibody Against Hepatocyte Growth Factor, in Cancer Patients

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2014-01-01

PREAI

Zhu, Min; Doshi, Sameer; Gisleskog, Per O.; Oliner, Kelly S.; Perez Ruixo, Juan Jose; Loh, Elwyn; Zhang, Yilong

Romiplostim doseresponse in patients with myelodysplastic syndromes

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2013-05-20

OAAI

Perez Ruixo, Juan Jose; Doshi, Sameer; Wang, Yow-Ming C.; Mould, Diane R.

Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer

MOLECULAR CANCER

IF33.9

2012-07-25

OAAI

Freeman, Daniel J.; McDorman, Kevin; Ogbagabriel, Selam; Kozlosky, Carl; Yang, Bing-Bing; Doshi, Sameer; Perez-Ruxio, Juan Jose; Fanslow, William; Starnes, Charlie; Radinsky, Robert

Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy Subjects

AAPS JOURNAL

IF3.7

2010-10-21

OAAI

Wang, Yow-Ming C.; Krzyzanski, Wojciech; Doshi, Sameer; Xiao, Jim J.; Perez-Ruixo, Juan Jose; Chow, Andrew T.

Identifying first in human (FIH) doses and schedule of U3-1287 (AMG 888), a fully human anti-HER3 mAb, based on preclinical pharmacokinetic (PK), pharmacodynamic (PD) and efficacy data

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-12-01

PREAI

Lum, Peggy; Ruixo, Juan Jose Perez; Ogbagabriel, Selam; Doshi, Sameer; Chen, Alin; Yang, Bing Bing; Hettman, Thore; Radinsky, Robert; Freeman, Dan

Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role (vol 98, pg 2198, 2008)

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2009-10-01

PREAI

Agoram, Balaji; Aoki, Ken; Doshi, Sameer; Gegg, Colin; Jang, Graham; Molineux, Graham; Narhi, Linda; Elliott, Steve

Investigation of the Effects of Altered Receptor Binding Activity on the Clearance of Erythropoiesis-Stimulating Proteins: Nonerythropoietin Receptor-Mediated Pathways may Play a Major Role

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2009-06-01

PREAI

Agoram, Balaji; Aoki, Ken; Doshi, Sameer; Gegg, Colin; Jang, Graham; Molineux, Graham; Narhi, Linda; Elliott, Steve

Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas

JOURNAL OF NEURO-ONCOLOGY

IF3.1

2004-07-01

PREAI

Schmidt, KF; Ziu, M; Schmidt, NO; Vaghasia, P; Cargioli, TG; Doshi, S; Albert, MS; Black, PM; Carroll, RS; Sun, YP

Perfusion MRI of U87 brain tumors in a mouse model

MAGNETIC RESONANCE IN MEDICINE

IF3

2004-04-26

PREAI

Sun, YP; Schmidt, NO; Schmidt, K; Doshi, S; Rubin, JB; Mulkern, RV; Carroll, R; Ziu, M; Erkmen, K; Poussaint, TY; Black, P; Albert, M; Burstein, D; Kieran, MW

研究方向